These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
487 related items for PubMed ID: 15869477
1. Striatal expression of GDNF and differential vulnerability of midbrain dopaminergic cells. Barroso-Chinea P, Cruz-Muros I, Aymerich MS, Rodríguez-Díaz M, Afonso-Oramas D, Lanciego JL, González-Hernández T. Eur J Neurosci; 2005 Apr; 21(7):1815-27. PubMed ID: 15869477 [Abstract] [Full Text] [Related]
2. Alterations in the expressions of mRNA for GDNF and its receptors in the ventral midbrain of rats exposed to subchronic phencyclidine. Semba J, Akanuma N, Wakuta M, Tanaka N, Suhara T. Brain Res Mol Brain Res; 2004 Apr 29; 124(1):88-95. PubMed ID: 15093689 [Abstract] [Full Text] [Related]
3. Efficient in vivo protection of nigral dopaminergic neurons by lentiviral gene transfer of a modified Neurturin construct. Fjord-Larsen L, Johansen JL, Kusk P, Tornøe J, Grønborg M, Rosenblad C, Wahlberg LU. Exp Neurol; 2005 Sep 29; 195(1):49-60. PubMed ID: 15919076 [Abstract] [Full Text] [Related]
4. Glial cell line-derived neurotrophic factor receptor GFRalpha1 is expressed in the rat striatum during postnatal development. Cho J, Yarygina O, Oo TF, Kholodilov NG, Burke RE. Brain Res Mol Brain Res; 2004 Aug 23; 127(1-2):96-104. PubMed ID: 15306125 [Abstract] [Full Text] [Related]
5. Expression of dopamine and vesicular monoamine transporters and differential vulnerability of mesostriatal dopaminergic neurons. González-Hernández T, Barroso-Chinea P, De La Cruz Muros I, Del Mar Pérez-Delgado M, Rodríguez M. J Comp Neurol; 2004 Nov 08; 479(2):198-215. PubMed ID: 15452855 [Abstract] [Full Text] [Related]
6. Effect of 6-hydroxydopamine on striatal GDNF and nigral GFRalpha1 and RET mRNAs in the adult rat. Smith AD, Antion M, Zigmond MJ, Austin MC. Brain Res Mol Brain Res; 2003 Oct 07; 117(2):129-38. PubMed ID: 14559146 [Abstract] [Full Text] [Related]
7. Quantitative analyses of GFRalpha-1 and GFRalpha-2 mRNAs and tyrosine hydroxylase protein in the nigrostriatal system reveal bilateral compensatory changes following unilateral 6-OHDA lesions in the rat. Kozlowski DA, Miljan EA, Bremer EG, Harrod CG, Gerin C, Connor B, George D, Larson B, Bohn MC. Brain Res; 2004 Aug 06; 1016(2):170-81. PubMed ID: 15246853 [Abstract] [Full Text] [Related]
8. Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo. Strömberg I, Björklund L, Johansson M, Tomac A, Collins F, Olson L, Hoffer B, Humpel C. Exp Neurol; 1993 Dec 06; 124(2):401-12. PubMed ID: 7904571 [Abstract] [Full Text] [Related]
9. Marked dopaminergic cell loss subsequent to developmental, intranigral expression of glial cell line-derived neurotrophic factor. Chun HS, Yoo MS, DeGiorgio LA, Volpe BT, Peng D, Baker H, Peng C, Son JH. Exp Neurol; 2002 Feb 06; 173(2):235-44. PubMed ID: 11822887 [Abstract] [Full Text] [Related]
10. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease. Zheng JS, Tang LL, Zheng SS, Zhan RY, Zhou YQ, Goudreau J, Kaufman D, Chen AF. Brain Res Mol Brain Res; 2005 Mar 24; 134(1):155-61. PubMed ID: 15790539 [Abstract] [Full Text] [Related]